| #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospi | ohne Phasenangabe | rekrutiert |
| A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melano | Phase II | rekrutiert |
| A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID- | Phase III | rekrutiert |
| A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-796 | Phase III | rekrutiert |
| A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients | Phase III | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adul | Phase I | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infant | Phase II | rekrutiert |
| A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies | Phase I / Phase II | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis | Phase III | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Multicenter Multinational Observational Study of Children With Hypochondroplasia | — | rekrutiert |
| A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tube | — | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases | Phase II | rekrutiert |
| A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOV | Phase II | rekrutiert |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With | Phase III | rekrutiert |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Inv | Phase III | rekrutiert |
| A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodi | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | Frühe Phase I | rekrutiert |
| A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall | — | rekrutiert |
| A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglob | — | rekrutiert |
| A Registry Study on HIV-related Lymphoma | — | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disea | Phase I | rekrutiert |
| A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carbopla | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Ref | Phase II | rekrutiert |
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Re | Phase I | rekrutiert |
| A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumita | Phase II | rekrutiert |
| A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treat | — | rekrutiert |
| A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell | Phase I / Phase II | rekrutiert |
| A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Ch | Phase III | rekrutiert |
| A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epider | Phase II | rekrutiert |
| A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone | Phase III | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Canc | — | rekrutiert |
| A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors Wit | Phase I / Phase II | rekrutiert |
| A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas | Phase I / Phase II | rekrutiert |
| A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies | Phase I / Phase II | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 D | Phase III | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers | Phase I | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tum | Phase I / Phase II | rekrutiert |
| A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic No | Phase II | rekrutiert |
| A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring | Phase I / Phase II | rekrutiert |
| A Study of Obexelimab in Patients With Systemic Lupus Erythematosus | Phase II | rekrutiert |
| A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Meta | Phase III | rekrutiert |
| A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Ca | Phase III | rekrutiert |
| A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide | Phase I | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory M | — | rekrutiert |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, | Phase I / Phase II | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-AD | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months | Phase II | rekrutiert |
| A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harbori | Phase I / Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Int | Phase II / Phase III | rekrutiert |
| A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia | — | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzuma | Phase II / Phase III | rekrutiert |
| A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma | Phase I | rekrutiert |
| A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Trea | — | rekrutiert |
| A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate | Phase I / Phase II | rekrutiert |
| A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel | Phase I / Phase II | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combi | Phase III | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis | Phase II | rekrutiert |
| A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 | Phase III | rekrutiert |
| A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High | Phase III | rekrutiert |
| A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants Wi | Phase III | rekrutiert |
| A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplan | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Mo | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Prima | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moder | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previous | Phase III | rekrutiert |
| A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults Wit | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilim | Phase I / Phase II | rekrutiert |
| A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With | Phase III | rekrutiert |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Foc | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies | Phase IV | rekrutiert |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotocl | Phase III | rekrutiert |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 i | Phase I | rekrutiert |
| A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Partic | Phase I | rekrutiert |
| A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome | Phase II | rekrutiert |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients Wit | Phase III | rekrutiert |
| A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis | — | rekrutiert |
| A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely | Phase III | rekrutiert |
| A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Stan | Phase III | rekrutiert |
| A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Th | Phase III | rekrutiert |
| A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standar | Phase III | rekrutiert |
| A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Les | Phase III | rekrutiert |
| A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other | Phase I | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Phase III | rekrutiert |
| A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part | Phase III | rekrutiert |
| A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma | Phase II / Phase III | rekrutiert |
| AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standa | ohne Phasenangabe | rekrutiert |
| ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants Wi | Phase II | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| ATLAS (AltaValve) Pivotal Trial | ohne Phasenangabe | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematolo | Phase I / Phase II | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA | Phase II / Phase III | rekrutiert |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Trea | Phase III | rekrutiert |
| An International Observational Study of Adults With Acute Infection | — | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA | Phase III | rekrutiert |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIA | — | rekrutiert |
| BIO|STREAM.CSP Study | — | rekrutiert |
| BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF | ohne Phasenangabe | rekrutiert |
| Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small | Phase II | rekrutiert |
| Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected St | Phase III | rekrutiert |
| Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseContr | ohne Phasenangabe | rekrutiert |
| Blood Flow Restriction Training in Acute Geriatric Rehabilitation | ohne Phasenangabe | rekrutiert |
| Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET) | — | rekrutiert |
| Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke | ohne Phasenangabe | rekrutiert |
| CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Afli | Phase III | rekrutiert |
| CAR-T Long Term Follow Up (LTFU) Study | Phase III | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | — | rekrutiert |
| CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1 | — | rekrutiert |
| CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitu | Phase III | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only i | ohne Phasenangabe | rekrutiert |
| Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Performance and Safety Assessment of the Use of iCover Balloon Expandable Covered Stent | ohne Phasenangabe | rekrutiert |
| Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and | Phase I | rekrutiert |
| Cologne Cohort of Neutropenic Patients (CoCoNut) | — | rekrutiert |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma | — | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant B | ohne Phasenangabe | rekrutiert |
| Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to C | Phase III | rekrutiert |
| DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device | — | rekrutiert |
| Deep Brain Stimulation (DBS) Retrospective Outcomes Study | — | rekrutiert |
| Device Global Registry for the IlluminOss Bone Stabilization System | — | rekrutiert |
| Dietary Interventions During Living Kidney Donations | ohne Phasenangabe | rekrutiert |
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma | Phase II | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| ECMM Candida Registry - CandiReg | — | rekrutiert |
| Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moder | Phase II | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK | Phase II | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity o | Phase III | rekrutiert |
| Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight- | Phase III | rekrutiert |
| Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring S | Phase III | rekrutiert |
| Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment with or Without Sonrotoclax for | Phase II | rekrutiert |
| Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock | ohne Phasenangabe | rekrutiert |
| Efficacy of INM004 in Children With STEC-HUS | Phase III | rekrutiert |
| Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) | Phase III | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial | ohne Phasenangabe | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | Phase II | rekrutiert |
| European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS | ohne Phasenangabe | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observati | — | rekrutiert |
| Extension Study for the Port Delivery System With Ranibizumab (Portal) | Phase III | rekrutiert |
| FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early P | ohne Phasenangabe | rekrutiert |
| FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alte | Phase I / Phase II | rekrutiert |
| FMRI-neurofeedback in Parkinson's Disease | ohne Phasenangabe | rekrutiert |
| FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC | Phase I / Phase II | rekrutiert |
| FungiScope - A Global Emerging Fungal Infection Registry | — | rekrutiert |
| GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| German Cardiac Arrest Registry | — | rekrutiert |
| German Centre for Infection Research HIV Translational Platform | — | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment | — | rekrutiert |
| Global Registry and Natural History Study for Mitochondrial Disorders | — | rekrutiert |
| Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Tra | ohne Phasenangabe | rekrutiert |
| HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Regi | — | rekrutiert |
| HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of L | Phase III | rekrutiert |
| Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study | — | rekrutiert |
| Hantavirus Registry - HantaReg | — | rekrutiert |
| High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | Phase III | rekrutiert |
| IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients | ohne Phasenangabe | rekrutiert |
| Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps | — | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| International (Pediatric) Peritoneal Biobank | — | rekrutiert |
| International CIPN Assessment and Validation Study | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Investigation of the Audible ICD Alert Tone | — | rekrutiert |
| KetoNiFast: Cyclic Enteral Daytime Feeding With Ketogenic Nighttime Fasting | ohne Phasenangabe | rekrutiert |
| LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated | Phase I / Phase II | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis | — | rekrutiert |
| Leptospirosis Registry - LeptoScope | — | rekrutiert |
| Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Pha | Phase III | rekrutiert |
| Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | Phase II / Phase III | rekrutiert |
| Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies | ohne Phasenangabe | rekrutiert |
| Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator | — | rekrutiert |
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | Phase III | rekrutiert |
| Mechanisms Of Disease Progression in Aortic Stenosis - the MODAS Study | — | rekrutiert |
| Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL | Phase II | rekrutiert |
| MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | rekrutiert |
| Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset | — | rekrutiert |
| NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometr | — | rekrutiert |
| NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High- | — | rekrutiert |
| National Network Genomic Medicine Lung Cancer, Germany | — | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <3 | — | rekrutiert |
| Next-Generation-Sequencing Approach to Neutropenic Sepsis | — | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis | — | rekrutiert |
| ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | Phase III | rekrutiert |
| Observational Study Protocol: LIVER-R | — | rekrutiert |
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours U | — | rekrutiert |
| Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) | Phase III | rekrutiert |
| PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different | Phase II | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| Pan Tumor Rollover Study | Phase II | rekrutiert |
| Patient Retrospective Outcomes (PRO) | — | rekrutiert |